Skip to main content
NRSN logo

NRSN · NeuroSense Therapeutics Ltd.

$0.59 -0.06 (-9.36%) At close · Jul 24
Market Cap
$21.74M
Shares
36.10M

Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.

Filed Type Offering Sold
2024-12-12 New $5,000,000 $5,000,000
2024-04-25 New $4,470,000 $4,470,000
2023-07-05 New $4,500,000 $4,500,000
Showing 1–3 of 3 filings
Key facts CIK 1875091 CUSIP M74240108 13F (30d) 1 filings 1 filers Visit website Investor relations